GlassScriptPhysician profile
Bianca Thorpe
NPI 1518278449
$6,042.00
in general payments reported to CMS, 2019-2025
40 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,239 · 2020: $525 · 2021: $952 · 2022: $955 · 2023: $317 · 2024: $627 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,507.56 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $898.97 | 2019-2025 | Wegovy, Ozempic |
| Pfizer INC. | $579.92 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $333.01 | 2019-2022 | |
| Abbvie INC. | $328.68 | 2021-2024 | Vraylar |
| Lilly USA, LLC | $295.33 | 2019-2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $260.84 | 2019-2023 | Belsomra, Steglujan, Steglatro |
| Amgen INC. | $220.05 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $151.56 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.00 | 2019-2023 | Jardiance |
| Glaxosmithkline, LLC. | $143.70 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $136.32 | 2019-2020 | |
| Mylan Specialty L.P. | $85.21 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.81 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $79.53 | 2021-2024 | Linzess |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Thorpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.